| ข่าวการออกและเสนอขาย | สถิติการเสนอขาย | All Document * สำหรับผู้ที่ใช้งาน Internet Explorer version 7.0 (IE 7) เป็นต้นไป ในกรณีที่ท่านเลือกใช้งานเมนูต่างๆ ในโปรแกรมค้นหาข้อมูลเผยแพร่ของบริษัทจดทะเบียน
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
23.6% YoY to THB 343mn Full-quarter recognition of ‘International Advertising’ Recognised net loss from non-recurring expenses of THB 180mn from impairment of assets, loss on disposal/ write-off of
reduction in customer contact leads to a decrease in selling expenses such as expenses related to customers, etc. Furthermore, the cost of impairment loss on financial assets in 2021 decreased by 93.4 million
total revenue, compared to 11.2 percent for the same period of year 2018. 3. Financial Status (Company and Subsidiaries) (1) Total Assets Company’s total assets as of September 30, 2019 was 1,576.1
-455-2888 Fax: 02-455-2763 Statement of Financial Position Unit: Million Baht 30 June 2017 31 December 2016 Increased (Decreased) Percentage Assets Current assets Cash and cash equivalents 218.61 286.51
, therefore financial cost for the 3 months of 2017 was more than previous year. Statement of Financial Position Unit: Million Baht 30 September 2017 31 December 2016 Increased (Decreased) Percentage Assets
: Million Baht 30 September 2017 31 December 2016 Increased (Decreased) Percentage Assets Current assets Cash and cash equivalents 228.83 286.51 (57.68) (20.13%) Temporary investments 60.33 69.97 (9.64